Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sparano, Francesco"'
Autor:
Van Hemelrijck M; School of Cancer and Pharmaceutical Sciences, Translational Oncology and Urology Research (TOUR), King's College London, London, UK., Sparano F; Data Center and Health Outcomes Research Unit, Italian Group for Adult Hematologic Disease (GIMEMA), Rome, Italy., Moris L; University Hospitals Leuven, Leuven, Belgium., Beyer K; School of Cancer and Pharmaceutical Sciences, Translational Oncology and Urology Research (TOUR), King's College London, London, UK., Cottone F; Data Center and Health Outcomes Research Unit, Italian Group for Adult Hematologic Disease (GIMEMA), Rome, Italy., Sprangers M; Department of Medical Psychology, Amsterdam University Medical Centers, Location Academic Medical Center, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands., Efficace F; Data Center and Health Outcomes Research Unit, Italian Group for Adult Hematologic Disease (GIMEMA), Rome, Italy.
Publikováno v:
Cancer medicine [Cancer Med] 2020 Jun; Vol. 9 (12), pp. 4039-4058. Date of Electronic Publication: 2020 Apr 25.
Autor:
Sparano F; Italian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Via Benevento, 6, 00161, Rome, Italy., Cavo M; Institute of Hematology 'L. and A. Seràgnoli', Department of Experimental, Diagnostic and Specialty Medicine, 'S.Orsola-Malpighi' University Hospital, University of Bologna, Bologna, Italy., Niscola P; Hematology Unit, S Eugenio Hospital, Rome, Italy., Caravita T; Hematology Unit, S Eugenio Hospital, Rome, Italy., Efficace F; Italian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Via Benevento, 6, 00161, Rome, Italy. f.efficace@gimema.it.
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2018 Jul; Vol. 26 (7), pp. 2075-2090. Date of Electronic Publication: 2018 Mar 20.
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 26(7)
We performed a systematic review to quantify the amount of evidence-based data available on patient-reported outcomes (PRO) in Relapsed/Refractory Multiple Myeloma (RRMM) patients and to examine the added value of such studies in supporting clinical